Novel viral vector construct for neuron specific continuous DOPA synthesis in vivo

Details for Australian Patent Application No. 2010316982 (hide)

Owner Genepod Therapeutics AB

Inventors Bjorklund, Tomas; Bjorklund, Anders; Kirik, Deniz

Agent FB Rice

Pub. Number AU-A-2010316982

PCT Pub. Number WO2011/054976

Priority 61/259,502 09.11.09 US

Filing date 9 November 2010

Wipo publication date 12 May 2011

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12N 15/86 (2006.01) Mutation or genetic engineering - Viral vectors

C12N 15/864 (2006.01) Mutation or genetic engineering - Parvoviral vectors

Event Publications

14 June 2012 PCT application entered the National Phase

  PCT publication WO2011/054976 Priority application(s): WO2011/054976

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010316989-Mechanism for absorbing kinetic energy from frontal impacts of vehicles against vehicle restraining systems, for using on the edges and central reservations of roadways, such as shock absorbers and barrier ends

2010316952-Method for expanding and/or preserving cells by means of gas enrichment of the culture medium